Accordingly, Ruffini et al. observed that CD8+ cells were associated with prolonged survival in 1290 stage I-IIIA NSCLC patients, but that an independent prognostic impact was associated with squamous cell carcinomas only [30]. This evidence concerns the gene CD8A and squamous cell carcinoma.